Why you should be attending?

  • Discover the latest in vivo gene engineering techniques to improve safety, tolerability and efficacy

  • Uncover the potential of combining modalities by leveraging the power of CAR technology across T-cells, NK cells, TILs,

  • Elevate your CMC and analytical workstreams to optimize development of safe and high-quality cell products

  • Achieve success during early phase 1/2 development as seasoned industry experts

Who attends?

  • Cell Therapy Academics and Clinicians

  • Pharma and Biotech Companies

  • Cell Therapy Researchers

  • Bioprocess Development

  • Product Research and Development

  • Cellular Immunotherapy Manufacturing Industries

  • Cell Engineering Labs and Organizations

  • Novel Vector Systems

  • Bioengineering based labs

Conveners

Dr. Navin Khattry
Deputy Director,
Clinical Research Centre , ACTREC, Tata Memorial Center, Mumbai.
Mr. Manoj Ramakrishna
Marketing Leader
South Asia, Cytiva.

Chair of the Scientific Committee

Dr. (Surg Cdr) Gaurav Narula
Founder & Professor Paediatric Oncology & Health Sciences
Principal Investigator CAR T Cell Therapy Centre & Cell Therapy Program Tata Memorial Center, HBNI, Mumbai.
“This workshop is a unique opportunity for all clinicians, scientists & researchers to deep dive into Cell Therapy Manufacturing and have hands-on experience”
Dr. (Surg Cdr) Gaurav Narula

Organizing Secretaries

Dr. Albeena Nisar
Scientific Officer D Senior Lead, Process Development, Analytics & Clinical Manufacturing, CAR T & Cell Therapy Centre ACTREC, Tata Memorial Center, Mumbai.
Dr. Likesh Sharma
Product Manager Cell & Gene Therapy, Cytiva
“The most exciting time in the field of medicine with the success of CAR T & Cellular Therapies”
Dr. Navin Khattry

Registration Questionnaire - SACT 2023